Hilary Smith Connery, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Opioid-Related Disorders | 25 | 2024 | 2138 | 2.530 |
Why?
|
Buprenorphine | 16 | 2024 | 654 | 1.700 |
Why?
|
Substance-Related Disorders | 14 | 2023 | 4371 | 1.280 |
Why?
|
Narcotic Antagonists | 13 | 2024 | 583 | 1.030 |
Why?
|
Naltrexone | 5 | 2015 | 317 | 0.900 |
Why?
|
Opiate Substitution Treatment | 9 | 2024 | 436 | 0.730 |
Why?
|
Methadone | 3 | 2024 | 320 | 0.630 |
Why?
|
Suicide | 7 | 2023 | 1599 | 0.550 |
Why?
|
Naloxone | 8 | 2015 | 369 | 0.530 |
Why?
|
Motivation | 3 | 2022 | 1993 | 0.510 |
Why?
|
Alcoholism | 7 | 2016 | 1961 | 0.480 |
Why?
|
Self-Injurious Behavior | 4 | 2023 | 554 | 0.470 |
Why?
|
Patient Dropouts | 1 | 2016 | 412 | 0.460 |
Why?
|
Death | 1 | 2018 | 678 | 0.450 |
Why?
|
Pregnancy, Unplanned | 1 | 2014 | 88 | 0.430 |
Why?
|
Suicidal Ideation | 2 | 2022 | 1425 | 0.430 |
Why?
|
Survivors | 2 | 2022 | 2375 | 0.410 |
Why?
|
Contraception Behavior | 1 | 2014 | 180 | 0.400 |
Why?
|
Substance Abuse Detection | 2 | 2014 | 301 | 0.400 |
Why?
|
Analgesics, Opioid | 11 | 2024 | 3763 | 0.400 |
Why?
|
Pregnancy Complications | 5 | 2024 | 2942 | 0.370 |
Why?
|
Students, Medical | 1 | 2024 | 1927 | 0.360 |
Why?
|
Tuberculosis | 5 | 2013 | 2001 | 0.330 |
Why?
|
Pregnant Women | 1 | 2014 | 563 | 0.320 |
Why?
|
Mental Health Services | 1 | 2020 | 1717 | 0.320 |
Why?
|
Sexually Transmitted Diseases | 1 | 2014 | 628 | 0.310 |
Why?
|
Health Personnel | 1 | 2020 | 3310 | 0.270 |
Why?
|
Prenatal Care | 1 | 2014 | 1129 | 0.270 |
Why?
|
Mental Health | 2 | 2020 | 3213 | 0.270 |
Why?
|
Adolescent Behavior | 1 | 2014 | 1175 | 0.250 |
Why?
|
Russia | 7 | 2016 | 381 | 0.240 |
Why?
|
Clubfoot | 1 | 2024 | 87 | 0.210 |
Why?
|
Cause of Death | 4 | 2022 | 3725 | 0.210 |
Why?
|
Mentally Ill Persons | 1 | 2003 | 127 | 0.200 |
Why?
|
Neural Tube Defects | 1 | 2024 | 254 | 0.190 |
Why?
|
Insurance | 1 | 2023 | 114 | 0.190 |
Why?
|
Foramen Ovale, Patent | 1 | 2024 | 214 | 0.190 |
Why?
|
Asphyxia | 2 | 2018 | 60 | 0.190 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2024 | 491 | 0.190 |
Why?
|
Psychotherapy, Group | 2 | 2014 | 410 | 0.180 |
Why?
|
Alcohol-Related Disorders | 3 | 2013 | 235 | 0.180 |
Why?
|
Terrorism | 1 | 2003 | 211 | 0.170 |
Why?
|
United States | 20 | 2024 | 72461 | 0.160 |
Why?
|
Heroin | 1 | 2019 | 119 | 0.160 |
Why?
|
Humans | 55 | 2024 | 760621 | 0.160 |
Why?
|
Risk-Taking | 3 | 2016 | 998 | 0.160 |
Why?
|
Capacity Building | 1 | 2020 | 257 | 0.150 |
Why?
|
Ambulatory Care Facilities | 1 | 2024 | 926 | 0.150 |
Why?
|
Counseling | 7 | 2015 | 1548 | 0.150 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2024 | 2496 | 0.150 |
Why?
|
Developed Countries | 1 | 2020 | 442 | 0.150 |
Why?
|
Crime | 1 | 2018 | 202 | 0.140 |
Why?
|
Receptors, Dopamine D2 | 3 | 2002 | 485 | 0.140 |
Why?
|
Dopamine Agonists | 3 | 2002 | 352 | 0.140 |
Why?
|
Policy | 1 | 2021 | 511 | 0.140 |
Why?
|
Spiritual Therapies | 1 | 2017 | 60 | 0.140 |
Why?
|
Phenanthridines | 3 | 2002 | 51 | 0.140 |
Why?
|
Poisoning | 1 | 2018 | 252 | 0.140 |
Why?
|
Curriculum | 2 | 2024 | 3718 | 0.140 |
Why?
|
Fentanyl | 1 | 2019 | 434 | 0.130 |
Why?
|
Outpatients | 3 | 2023 | 1607 | 0.130 |
Why?
|
Psychotherapy | 3 | 2014 | 1640 | 0.130 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 496 | 0.130 |
Why?
|
Female | 39 | 2024 | 391270 | 0.130 |
Why?
|
Pregnancy | 8 | 2024 | 29749 | 0.130 |
Why?
|
Self Report | 2 | 2019 | 3711 | 0.130 |
Why?
|
Heroin Dependence | 1 | 2016 | 172 | 0.130 |
Why?
|
Irritable Mood | 1 | 2016 | 194 | 0.130 |
Why?
|
Wounds, Gunshot | 2 | 2018 | 581 | 0.120 |
Why?
|
Intention | 1 | 2018 | 345 | 0.120 |
Why?
|
Prescription Drugs | 2 | 2014 | 630 | 0.120 |
Why?
|
Adult | 28 | 2024 | 219994 | 0.120 |
Why?
|
Premature Birth | 2 | 2024 | 1771 | 0.110 |
Why?
|
Religion | 1 | 2017 | 376 | 0.110 |
Why?
|
Alcohol Deterrents | 1 | 2013 | 49 | 0.110 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 622 | 0.100 |
Why?
|
Young Adult | 11 | 2024 | 58741 | 0.100 |
Why?
|
Women | 1 | 2014 | 225 | 0.100 |
Why?
|
Psychiatry | 2 | 2015 | 1689 | 0.100 |
Why?
|
Ethanol | 1 | 2018 | 1323 | 0.100 |
Why?
|
Rural Population | 1 | 2003 | 2268 | 0.100 |
Why?
|
Urinalysis | 1 | 2014 | 368 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2022 | 2062 | 0.100 |
Why?
|
Behavior Therapy | 3 | 2013 | 868 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2016 | 831 | 0.100 |
Why?
|
Attitude of Health Personnel | 3 | 2014 | 3865 | 0.100 |
Why?
|
Male | 31 | 2022 | 359744 | 0.090 |
Why?
|
Marijuana Abuse | 2 | 2013 | 411 | 0.090 |
Why?
|
Psychotropic Drugs | 2 | 2007 | 883 | 0.090 |
Why?
|
Self Efficacy | 2 | 2007 | 630 | 0.090 |
Why?
|
Infant, Small for Gestational Age | 2 | 2024 | 460 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2016 | 3986 | 0.090 |
Why?
|
Forecasting | 2 | 2022 | 2932 | 0.090 |
Why?
|
Attitude to Health | 2 | 2016 | 2029 | 0.090 |
Why?
|
Pregnancy Trimester, First | 2 | 2024 | 908 | 0.090 |
Why?
|
Adolescent | 10 | 2023 | 87810 | 0.080 |
Why?
|
Internship and Residency | 3 | 2021 | 5870 | 0.080 |
Why?
|
Infant, Low Birth Weight | 2 | 2024 | 859 | 0.080 |
Why?
|
Developing Countries | 1 | 2020 | 2868 | 0.070 |
Why?
|
Yawning | 1 | 1997 | 5 | 0.070 |
Why?
|
Risk Reduction Behavior | 1 | 2014 | 1109 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2024 | 4673 | 0.070 |
Why?
|
Sleep Apnea Syndromes | 1 | 2015 | 974 | 0.070 |
Why?
|
Mastication | 1 | 1997 | 53 | 0.070 |
Why?
|
Patient Care Management | 1 | 2009 | 303 | 0.070 |
Why?
|
Middle Aged | 15 | 2022 | 220352 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2477 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14495 | 0.060 |
Why?
|
Patient Compliance | 5 | 2014 | 2688 | 0.060 |
Why?
|
Combined Modality Therapy | 6 | 2015 | 8552 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2016 | 2064 | 0.060 |
Why?
|
Cesarean Section | 2 | 2024 | 1385 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2003 | 4555 | 0.060 |
Why?
|
Risk Factors | 4 | 2016 | 74359 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2011 | 6015 | 0.060 |
Why?
|
Locomotion | 1 | 1997 | 387 | 0.060 |
Why?
|
Patient Selection | 2 | 2014 | 4283 | 0.060 |
Why?
|
Population Surveillance | 3 | 2020 | 2608 | 0.060 |
Why?
|
Social Support | 1 | 2014 | 2145 | 0.060 |
Why?
|
Physicians | 2 | 2013 | 4591 | 0.050 |
Why?
|
Neonatal Abstinence Syndrome | 1 | 2024 | 108 | 0.050 |
Why?
|
Pregnancy Outcome | 2 | 2024 | 2907 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2283 | 0.050 |
Why?
|
Synaptic Membranes | 1 | 2002 | 89 | 0.050 |
Why?
|
Pituitary Gland, Anterior | 1 | 2002 | 142 | 0.050 |
Why?
|
Risk Assessment | 2 | 2016 | 24123 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25942 | 0.050 |
Why?
|
Anxiety | 1 | 2016 | 4538 | 0.050 |
Why?
|
Sickness Impact Profile | 1 | 2003 | 298 | 0.050 |
Why?
|
Ambulatory Care | 3 | 2021 | 2781 | 0.050 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2024 | 338 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2014 | 8056 | 0.050 |
Why?
|
Hospitalization | 2 | 2019 | 10790 | 0.050 |
Why?
|
Self Concept | 1 | 2007 | 1039 | 0.050 |
Why?
|
Sexual Behavior | 1 | 2010 | 2086 | 0.050 |
Why?
|
Cohort Studies | 4 | 2024 | 41335 | 0.050 |
Why?
|
Treatment Outcome | 11 | 2017 | 65017 | 0.040 |
Why?
|
Death Certificates | 1 | 2020 | 167 | 0.040 |
Why?
|
New England | 1 | 2023 | 1050 | 0.040 |
Why?
|
Community Mental Health Services | 1 | 2003 | 392 | 0.040 |
Why?
|
Accidents | 1 | 2020 | 166 | 0.040 |
Why?
|
Live Birth | 1 | 2022 | 512 | 0.040 |
Why?
|
Forensic Pathology | 1 | 2018 | 23 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5423 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2018 | 147 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10344 | 0.040 |
Why?
|
Methods | 1 | 2018 | 1074 | 0.040 |
Why?
|
Hospitals, Private | 1 | 2017 | 63 | 0.040 |
Why?
|
HIV Infections | 2 | 2016 | 17165 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3164 | 0.030 |
Why?
|
Postpartum Period | 1 | 2023 | 1167 | 0.030 |
Why?
|
Hospitals, Psychiatric | 1 | 2017 | 320 | 0.030 |
Why?
|
Writing | 1 | 2018 | 199 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29658 | 0.030 |
Why?
|
Temperance | 1 | 2015 | 87 | 0.030 |
Why?
|
Autopsy | 1 | 2018 | 1007 | 0.030 |
Why?
|
Unsafe Sex | 1 | 2016 | 213 | 0.030 |
Why?
|
Transfection | 1 | 2002 | 5781 | 0.030 |
Why?
|
Violence | 1 | 2020 | 927 | 0.030 |
Why?
|
Sex Factors | 2 | 2022 | 10547 | 0.030 |
Why?
|
Recurrence | 2 | 2018 | 8482 | 0.030 |
Why?
|
Research Design | 1 | 2010 | 6180 | 0.030 |
Why?
|
Internal Medicine | 1 | 2021 | 1048 | 0.030 |
Why?
|
Time | 1 | 2015 | 545 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2024 | 26181 | 0.030 |
Why?
|
Teaching | 1 | 2021 | 1169 | 0.030 |
Why?
|
Case Management | 1 | 2014 | 272 | 0.030 |
Why?
|
Medical Records | 1 | 2018 | 1407 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1201 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2013 | 10827 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36060 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 636 | 0.020 |
Why?
|
Mood Disorders | 1 | 2018 | 1124 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2003 | 3696 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2015 | 613 | 0.020 |
Why?
|
Narcotics | 1 | 2013 | 336 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1399 | 0.020 |
Why?
|
Prolactin | 2 | 2002 | 621 | 0.020 |
Why?
|
Aged | 6 | 2022 | 169152 | 0.020 |
Why?
|
Medically Underserved Area | 1 | 2012 | 257 | 0.020 |
Why?
|
Suicide, Attempted | 1 | 2018 | 1378 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 3 | 2002 | 8158 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12965 | 0.020 |
Why?
|
Directive Counseling | 1 | 2010 | 171 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2011 | 810 | 0.020 |
Why?
|
Remoxipride | 1 | 1997 | 2 | 0.020 |
Why?
|
Idazoxan | 1 | 1997 | 12 | 0.020 |
Why?
|
Adrenergic alpha-2 Receptor Antagonists | 1 | 1997 | 18 | 0.020 |
Why?
|
Apomorphine | 1 | 1997 | 149 | 0.020 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1997 | 174 | 0.020 |
Why?
|
Receptors, Dopamine D3 | 1 | 1997 | 107 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 2628 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2012 | 830 | 0.020 |
Why?
|
Health Surveys | 1 | 2016 | 4063 | 0.020 |
Why?
|
Dopamine Antagonists | 1 | 1997 | 288 | 0.020 |
Why?
|
Stereoisomerism | 1 | 1997 | 617 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 13308 | 0.020 |
Why?
|
Substance Abuse, Intravenous | 1 | 2010 | 530 | 0.020 |
Why?
|
Inpatients | 1 | 2017 | 2581 | 0.020 |
Why?
|
Program Development | 1 | 2012 | 1297 | 0.020 |
Why?
|
Sex Distribution | 1 | 2010 | 2295 | 0.020 |
Why?
|
Age Factors | 1 | 2022 | 18416 | 0.020 |
Why?
|
Dopamine | 2 | 2002 | 1595 | 0.020 |
Why?
|
Benzazepines | 1 | 1997 | 311 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2010 | 968 | 0.010 |
Why?
|
Disease Management | 1 | 2015 | 2514 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8803 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 80372 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9631 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1988 | 0.010 |
Why?
|
Cocaine-Related Disorders | 1 | 2007 | 460 | 0.010 |
Why?
|
Rats | 3 | 2002 | 23711 | 0.010 |
Why?
|
Regression Analysis | 1 | 2013 | 6360 | 0.010 |
Why?
|
Reference Standards | 1 | 1997 | 1004 | 0.010 |
Why?
|
Mental Disorders | 1 | 2003 | 6796 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2696 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2363 | 0.010 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2003 | 303 | 0.010 |
Why?
|
Rhode Island | 1 | 2003 | 349 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5201 | 0.010 |
Why?
|
Drug Interactions | 1 | 1997 | 1428 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39261 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1784 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8469 | 0.010 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2009 | 936 | 0.010 |
Why?
|
Biological Availability | 1 | 2002 | 395 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6498 | 0.010 |
Why?
|
Tobacco Use Disorder | 1 | 2007 | 700 | 0.010 |
Why?
|
Goals | 1 | 2006 | 708 | 0.010 |
Why?
|
Patient Care Planning | 1 | 2006 | 908 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2002 | 1142 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2002 | 680 | 0.010 |
Why?
|
Psychometrics | 1 | 2010 | 3051 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12159 | 0.010 |
Why?
|
Potassium Channels | 1 | 2002 | 534 | 0.010 |
Why?
|
Pituitary Gland | 1 | 2002 | 637 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2002 | 1095 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1997 | 6238 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13314 | 0.010 |
Why?
|
Depression | 1 | 2018 | 8044 | 0.010 |
Why?
|
Pain | 1 | 2013 | 5066 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2022 | 58995 | 0.010 |
Why?
|
Corpus Striatum | 1 | 2002 | 1233 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10551 | 0.010 |
Why?
|
Health Services Research | 1 | 2003 | 1810 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15840 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14660 | 0.010 |
Why?
|
Program Evaluation | 1 | 2003 | 2493 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2012 | 5325 | 0.010 |
Why?
|
Computer Simulation | 1 | 1997 | 6218 | 0.010 |
Why?
|
Prevalence | 1 | 2007 | 15687 | 0.010 |
Why?
|
Child | 1 | 2016 | 79806 | 0.000 |
Why?
|
Cell Line | 1 | 2002 | 15620 | 0.000 |
Why?
|
Animals | 3 | 2002 | 167963 | 0.000 |
Why?
|